Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 27.60% is 376% above its 5-year average of 5.80%, near the high end of its 5-year range (-30.25%–33.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.59% below its 12-month average of 29.55%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 27.60%.
RETURN ON INVESTED CAPITAL (ROIC)
27.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
29.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
21.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
5.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-20.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-31.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-31.38%
CURRENT VS TTM AVG
-6.59%
CURRENT VS 3Y AVG
+26.39%
CURRENT VS 5Y AVG
+376.18%
CURRENT VS 10Y AVG
+232.62%
CURRENT VS 15Y AVG
+187.96%
CURRENT VS 20Y AVG
+187.96%
SECTOR MEDIAN · HEALTHCARE
-28.69%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
+196.21%
vs the sector median at left
ADMA Biologics, Inc.
Market Cap
$2.34B
Return on Invested Capital (ROIC)
27.60%
TTM Avg
29.55%
3Y Avg
21.84%
5Y Avg
5.80%
Market Cap
$2.31B
Return on Invested Capital (ROIC)
14.96%
TTM Avg
15.56%
3Y Avg
18.20%
5Y Avg
16.63%
Market Cap
$2.43B
Return on Invested Capital (ROIC)
-4.62%
TTM Avg
-19.11%
3Y Avg
-45.14%
5Y Avg
-60.93%
Market Cap
$2.43B
Return on Invested Capital (ROIC)
-38.21%
TTM Avg
-29.01%
3Y Avg
-27.76%
5Y Avg
-29.57%
Market Cap
$2.51B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.17B
Return on Invested Capital (ROIC)
-45.19%
TTM Avg
-39.97%
3Y Avg
-37.50%
5Y Avg
-32.54%
Market Cap
$2.11B
Return on Invested Capital (ROIC)
8.61%
TTM Avg
7.04%
3Y Avg
7.13%
5Y Avg
6.52%
Market Cap
$2.07B
Return on Invested Capital (ROIC)
3.61%
TTM Avg
5.05%
3Y Avg
-22.39%
5Y Avg
-28.34%
Market Cap
$2.06B
Return on Invested Capital (ROIC)
-89.73%
TTM Avg
-14.48%
3Y Avg
-24.76%
5Y Avg
-41.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADMA Biologics, Inc. (ADMA) | $2.34B | 27.60% | 29.55% | 21.84% | 5.80% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 14.96% | 15.56% | 18.20% | 16.63% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -4.62% | -19.11% | -45.14% | -60.93% |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | -38.21% | -29.01% | -27.76% | -29.57% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -49.78% | -43.13% | -47.40% | -42.10% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -45.19% | -39.97% | -37.50% | -32.54% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 8.61% | 7.04% | 7.13% | 6.52% |
| Alvotech (ALVO)vs › | $2.07B | 3.61% | 5.05% | -22.39% | -28.34% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | -89.73% | -14.48% | -24.76% | -41.39% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -28.96% | -36.25% | -29.21% | -30.95% |
ROIC
27.6%
ROE
41.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 27.60% |
| 2026-03-31 | 27.86% |
| 2025-12-31 | 27.62% |
| 2025-09-30 | 32.46% |
| 2025-06-30 | 32.19% |
| 2025-03-31 | 33.26% |
| 2024-12-31 | 32.09% |
| 2024-09-30 | 30.87% |
| 2024-06-30 | 22.44% |
| 2024-03-31 | 14.87% |
| 2023-12-31 | 7.74% |
| 2023-09-30 | 0.44% |
| 2023-06-30 | -5.53% |
| 2023-03-31 | -8.34% |
| 2022-12-31 | -12.73% |
| 2022-09-30 | -18.15% |
| 2022-06-30 | -19.20% |
| 2022-03-31 | -20.99% |
| 2021-12-31 | -23.74% |
| 2021-09-30 | -30.25% |
| 2021-06-30 | -28.78% |
| 2021-03-31 | -29.48% |
| 2020-12-31 | -34.58% |
| 2020-09-30 | -32.00% |
| 2020-06-30 | -28.42% |
| 2020-03-31 | -22.88% |
| 2019-12-31 | -36.64% |
| 2019-09-30 | -40.89% |
| 2019-06-30 | -41.22% |
| 2019-03-31 | -81.63% |
| 2018-12-31 | -76.07% |
| 2018-09-30 | -56.28% |
| 2018-06-30 | -49.55% |
| 2018-03-31 | -61.09% |
| 2017-12-31 | -39.88% |
| 2017-09-30 | -55.00% |
| 2017-06-30 | -29.10% |
| 2017-03-31 | -168.80% |
| 2016-12-31 | -93.31% |
| 2016-09-30 | -77.00% |
| 2016-06-30 | -69.18% |
| 2016-03-31 | -106.99% |
| 2015-12-31 | -79.57% |
| 2015-09-30 | -64.15% |
| 2015-06-30 | -50.63% |
| 2015-03-31 | -44.91% |
| 2014-12-31 | -69.56% |
| 2014-09-30 | -79.49% |
| 2014-06-30 | -67.76% |
| 2014-03-31 | -63.57% |
| 2013-12-31 | -53.11% |
| 2013-09-30 | -206.39% |
| 2013-06-30 | -155.66% |
| 2013-03-31 | -84.03% |
| 2012-12-31 | -57.57% |
| 2012-09-30 | -48.03% |
| 2012-06-30 | -16.36% |
| 2012-03-31 | -7.75% |
| 2011-12-31 | -1085.29% |
| 2011-03-31 | -215.50% |
| 2009-12-31 | -3356.21% |
| 2007-06-30 | -1527.88% |
